Treatment of allergic rhinitis during pregnancy

Drugs

Volumn 63, Issue 17, 2003, Pages 1813-1820

  Demoly, Pascal ^a,c   Piette, Vincent ^a   Daures, Jean Pierre ^b  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b UNIV MONTPELLIER   (France)

^c MONTPELLIER UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZELASTINE; BECLOMETASONE; BUDESONIDE; CETIRIZINE; CHLORPHENIRAMINE MALEATE; CHLORPROMAZINE; CROMOGLYCATE DISODIUM; DECONGESTIVE AGENT; DIPHENHYDRAMINE; EPHEDRINE; FLUNISOLIDE; FLUTICASONE PROPIONATE; GLUCOCORTICOID; HISTAMINE H1 RECEPTOR ANTAGONIST; HYDROXYZINE; IPRATROPIUM BROMIDE; LORATADINE; MOMETASONE FUROATE; NAPHAZOLINE; NEDOCROMIL; OXYMETAZOLINE; PHENYLEPHRINE; PREDNISONE; PROMETHAZINE; PSEUDOEPHEDRINE; TERATOGENIC AGENT; TRIAMCINOLONE; XYLOMETAZOLINE;

ALLERGIC RHINITIS; CARDIOVASCULAR MALFORMATION; CLEFT LIP; CLINICAL TRIAL; CONGENITAL MALFORMATION; DRUG ABSORPTION; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; GASTROSCHISIS; HUMAN; IMMUNOTHERAPY; NEUROTOXICITY; NONHUMAN; NOSE DISEASE; PREECLAMPSIA; PREGNANCY; REBOUND; REVIEW; RHINITIS MEDICAMENTOSA; SEDATION; TACHYPHYLAXIS; TERATOGENESIS;

ADMINISTRATION, INHALATION; ANIMALS; CHOLINERGIC ANTAGONISTS; CHROMONES; FEMALE; GLUCOCORTICOIDS; HISTAMINE H1 ANTAGONISTS; HUMANS; NASAL DECONGESTANTS; PRACTICE GUIDELINES; PREGNANCY; PREGNANCY COMPLICATIONS; RHINITIS, ALLERGIC, PERENNIAL; TERATOGENS;

ANIMALIA; ARIA;

EID: 0041832049     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200363170-00004     Document Type: Review

References (44)

1. Ellegard E, Karlsson G. Nasal congestion during pregnancy. Clin Otolaryngol 1999; 24: 307-11
2. Ellegard E, Karlsson G. IgE-mediated reactions and hyperreactivity in pregnancy rhinitis. Arch Otolaryngol Head Neck Surg 1999; 125: 1121-5
3. Sorri M, Hartikainen-Sorri AL, Karja J. Rhinitis during pregnancy. Rhinology 1980; 18: 83-6
4. The use of newer asthma and allergy medications during pregnancy. The American College of Obstetricians and Gynecologists (ACOG) and The American College of Allergy, Asthma and Immunology (ACAAI). Ann Allergy Asthma Immunol 2000; 84: 475-80
5. Schatz M. Special considerations for the pregnant woman and senior citizen with airway disease. J Allergy Clin Immunol 1998; 101: S373-8
6. Mazzotta P, Loebstein R, Koren G. Treating allergic rhinitis in pregnancy: safety considerations. Drug Saf 1999; 20: 361-75
7. Bousquet J, van-Cauwenberge P, Khaltaev N, et al. Allergic rhinitis and its impact on asthma (ARIA): in collaboration with the World Health Organization. J Allergy Clin Immunol 2001; 108: S1-S315
8. Weiner JM, Abramson MJ, Puy RM. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ 1998; 317: 1624-9
9. Ellegard EK, Hellgren M, Karlsson NG. Fluticasone propionate aqueous nasal spray in pregnancy rhinitis. Clin Otolaryngol 2001; 26: 394-400
10. Cave A, Arlett P, Lee E. Inhaled and nasal corticosteroids: factors affecting the risks of systemic adverse effects. Pharmacol Ther 1999; 83: 153-79
11. Kusanagi T. Occurrence of cleft palate, palatal slit, and fetal death in mice treated with a glucocorticoid: an embryo transfer experiment. Teratology 1983; 27: 395-400
12. Greenberger PA, Patterson R. Beclomethasone diproprionate for severe asthma during pregnancy. Ann Intern Med 1983; 98: 478-80
13. Briggs GC, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 8th ed. Baltimore (MD): Lippincott Williams & Wilkins, 1998
14. Kallen B, Rydhstroem H, Aberg A. Congenital malformations after the use of inhaled budesonide in early pregnancy. Obstet Gynecol 1999; 93: 392-5
15. Park-Wyllie L, Mazzotta P, Pastuszak A, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000; 62: 385-92
16. Reinisch JM, Simon NG, Karow WG, et al. Prenatal exposure to prednisone in humans and animals retards intrauterine growth. Science 1978; 202: 436-8
17. Schatz M, Zeiger RS, Harden K, et al. The safety of asthma and allergy medications during pregnancy. J Allergy Clin Immunol 1997; 100: 301-6
18. Schatz M, Patterson R, Zeitz S, et al. Corticosteroid therapy for the pregnant asthmatic patient. JAMA 1975; 233: 804-7
19. Snyder RD, Snyder D. Corticosteroids for asthma during pregnancy. Ann Allergy 1978; 41: 340-1
20. Orr TS. Mode of action of disodium cromoglycate. Acta Allergol 1977; 13: 9-27
21. Norris AA. Pharmacology of sodium cromoglycate. Clin Exp Allergy 1996; 4: 5-7
22. Wilson J. Use of sodium cromoglycate during pregnancy. Acta Ther 1982; 8: S45-51
23. Gengo FM, Manning C. A review of the effects of antihistamines on mental processes related to automobile driving. J Allergy Clin Immunol 1990; 86: 1034-9
24. Walker BE, Patterson A. Induction of cleft palate in mice by tranquilizers and barbiturates. Teratology 1974; 10: 159-63
25. King CT, Howell J. Teratogenic effect of buclizine and hydroxyzine in the rat and chlorcyclizine in the mouse. Am J Obstet Gynecol 1966; 95: 109-11
26. Saxen I. Cleft palate and maternal diphenhydramine intake. Lancet 1974; I: 407-8
27. Schatz M, Petitti D. Antihistamines and pregnancy. Ann Allergy Asthma Immunol 1997; 78: 157-9
28. Ciprandi G, Liccardi G, D'Amato G, et al. Treatment of allergic diseases during pregnancy. J Investig Allergol Clin Immunol 1997; 7: 557-65
29. Einarson A, Bailey B, Jung G, et al. Prospective controlled study of hydroxyzine and cetirizine in pregnancy. Ann Allergy Asthma Immunol 1997; 78: 183-6
30. Källén B. Drugs in pregnancy: the dilemma of labeling. Drug Inf J 1999; 33: 1135-43
31. Kallen B. Use of antihistamine drugs in early pregnancy and delivery outcome. J Matern Fetal Neonatal Med 2002; 11 (3): 146-52
32. The European Agency for the Evaluation of Medicinal Products. Committee for Proprietary Medicinal Products Meeting of 17 to 18 December 2002 [media release]. London: The European Agency for the Evaluation of Medicinal Products, 2002 Dec 19
33. Moretti ME, Caprara D, Coutinho CJ, et al. Fetal safety Of loratadine use in the first trimester of pregnancy: a multicenter study. J Allergy Clin Immunol 2003; 111 (3): 479-83
34. Wood CC, Fireman P, Grossman J, et al. Product characteristics and pharmacokinetics of intranasal ipratropium bromide. J Allergy Clin Immunol 1995; 95: 1111-6
35. Malm L. Pharmacological background to decongesting and anti-inflammatory treatment of rhinitis and sinusitis. Acta Otolaryngol Suppl 1994; 515: 53-5
36. Johnson DA, Hricik JG. The pharmacology of alpha-adrenergic decongestants. Pharmacotherapy 1993; 13: 110S-5S
37. Graf P, Hallen H, Juto JE. Four-week use of oxymetazoline nasal spray (Nezeril) once daily at night induces rebound swelling and nasal hyperreactivity. Acta Otolaryngol 1995; 115: 71-5
38. Kanfer I, Dowse R, Vuma V. Pharmacokinetics of oral decongestants. Pharmacotherapy 1993; 13: 116S-28S
39. Werler MM, Mitchell AA, Shapiro S. First trimester maternal medication use in relation to gastroschisis. Teratology 1992; 45: 361-7
40. Aselton P, Jick H, Milunsky A, et al. First-trimester drug use and congenital disorders. Obstet Gynecol 1985; 65: 451-5
41. Jick H, Holmes LB, Hunter JR, et al. First-trimester drug use and congenital disorders. JAMA 1981; 246: 343-6
42. Bousquet J, Lockey R, Malling HJ, et al. Allergen immunotherapy: therapeutic vaccines for allergic diseases: a WHO position paper. J Allergy Clin Immunol 1998; 102: 558-62
43. Metzger WJ, Turner E, Patterson R. The safety of immunotherapy during pregnancy. J Allergy Clin Immunol 1978; 61: 268-72
44. Nuutinen J, Holopainen E, Haahtela T, et al. Balanced physiological saline in the treatment of chronic rhinitis. Rhinology 1986; 24: 265-9